Advertisement

ALGN

Align Technology, Inc.

Healthcare · USD

Set alert

Price alert · ALGN

All alert types
149.89 USD -3.82 -2.49%
As of Oct 30, 2026 Extended hours 149.89 0.00%
Bid
149.91 × 2
Ask
150.00 × 2
147.57 Day range 155.54
132.28 52-week range 197.51
YTD
-4.01%
1 year
+8.28%
Open
153.98
Prev close
153.71
Mkt cap
10.65B
Vol
1.12M
Avg vol
930.42K
EPS
6.86
P/E
21.85
Div yield
0.00%
More statistics
Low
147.57
High
155.54
Forward P/E
12.03
Beta
1.67
Short ratio
4.23
Inst. own
104.26%
Dividend
0.00
Ex-div date
Earnings
Feb 3, 2027
50-d avg
150.64
200-d avg
168.91
1y target
186.50

5D chart

Chart tools
Interval
ALGN five-day price chart147.6149.8152.0154.3156.5Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
10.55B
Enterprise value
9.88B
Trailing P/E
21.64
Forward P/E
12.03
PEG ratio
0.65
Price / sales
2.54
Price / book
2.45
EPS (TTM)
6.86
Beta
1.67
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
11.83%
Revenue (TTM)
4.16B
Revenue growth
1.90%
Free cash flow
662.67M
Total cash
1.14B
Total debt
112.30M
Return on equity
11.90%
Shares outstanding
71.04M
Short % of float
6.67%
50-day average
150.64
200-day average
168.91

Analyst view

Consensus: buy

Buy
Price target (mean) 186.50 +24.4% upside
Target (low)
162.00
Target (mean)
186.50
Target (high)
210.00
Ratings (0m) 16 8 buy · 7 hold · 1 sell
  • Strong buy3
  • Buy5
  • Hold7
  • Sell0
  • Strong sell1

Next earnings

Feb 3, 2027

Expected Feb 3, 2027. Consensus EPS estimate 3.05.

Earnings history

Financials — quick view

All financials
ALGN Revenue — quarterly 1.06B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ALGN Net income — quarterly 108.29M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ALGN EPS — quarterly 1.51
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ALGN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 3, 2027Dec 30, 20263.09———
Oct 28, 2026Sep 30, 20262.772.80+0.03+1.08%
Jul 29, 2026Jun 30, 20262.622.64+0.02+0.76%
Apr 29, 2026Mar 31, 20262.302.58+0.28+12.17%
Feb 4, 2026Dec 31, 20252.993.29+0.30+10.03%
Oct 29, 2025Sep 30, 20252.402.61+0.21+8.75%

Upgrades / downgrades

ALGN analyst upgrades and downgrades
DateFirmActionFromTo
Oct 29, 2026Morgan StanleymainEqual-WeightEqual-Weight
Oct 22, 2026MizuhomainOutperformOutperform
Oct 21, 2026Piper SandlermainOverweightOverweight
Oct 15, 2026BairddownOutperformNeutral
Oct 14, 2026Leerink PartnersmainOutperformOutperform
Oct 9, 2026StifelmainBuyBuy

About Align Technology, Inc.

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on ALGN — it syncs with the Stock Master app.

Insider holders

ALGN insider holders
InsiderRelationLatest transactionDateShares held
COLETTI JULIE ANNOfficerConversion of Exercise of derivative securityFeb 19, 202611,445
DALLAS KEVIN J.DirectorConversion of Exercise of derivative securityMay 19, 202616,168
HOCKRIDGE STUART AOfficerConversion of Exercise of derivative securityFeb 19, 202614,892
HOGAN JOSEPH MChief Executive OfficerConversion of Exercise of derivative securityFeb 19, 2026266,037
LACOB JOSEPH SDirectorConversion of Exercise of derivative securityMay 19, 20260
LARKIN CHARLES RAYMOND JRDirectorConversion of Exercise of derivative securityMay 19, 202627,454

Institution ownership

ALGN institution ownership
Holder% heldSharesValueReported
Blackrock Inc.6.17%4,419,366656.03MJun 29, 2026
Vanguard Capital Management LLC6.15%4,401,313653.35MJun 29, 2026
FMR, LLC5.67%4,060,032602.69MJun 29, 2026
Capital International Investors5.65%4,045,561600.54MJun 29, 2026
Capital World Investors4.78%3,422,385508.04MJun 29, 2026
Goldman Sachs Group Inc4.71%3,372,760500.67MJun 29, 2026

Fund ownership

ALGN fund ownership
Holder% heldSharesValueReported
Fidelity Contrafund3.49%2,499,880371.09MAug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.02%2,161,368320.84MJun 29, 2026
NEW PERSPECTIVE FUND2.72%1,950,922289.60MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.41%1,725,219256.10MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.18%1,559,547231.51MJun 29, 2026
AMERICAN FUNDS FUNDAMENTAL INVESTORS1.80%1,288,759191.31MSep 29, 2026
Advertisement